
Integra LifeSciences Holdings Corporation IART
€ 9.43
-4.01%
Quartalsbericht 2025-Q2
hinzugefügt 31.07.2025
Land |
|
IPO-Jahr |
- |
Branche |
Medizinische Geräte |
Börse |
NASDAQ GLOBALSPB |
Anteile |
77 M |
Marktkapitalisierung |
$ 857 M |
EBITDA (LTM) |
$ -524 M |
P/E (LTM) |
-1.6 |
P/S (LTM) |
0.54 |
EPS (LTM) |
-6.94 |
Andere Aktien der Branche "Medizinische Geräte"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Delcath Systems
DCTH
|
$ 9.11 | -10.77 % | $ 260 M | Nasdaq Capital Market | ||
|
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Alphatec Holdings
ATEC
|
$ 13.94 | -0.71 % | $ 2.09 B | Nasdaq Global Select Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Cognyte Software Ltd.
CGNT
|
$ 7.0 | 5.74 % | $ 503 M | Nasdaq Global Select Market,SPB | ||
|
EDAP TMS S.A.
EDAP
|
$ 4.38 | -4.58 % | $ 163 M | Nasdaq Global Market | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
Apyx Medical Corporation
APYX
|
$ 3.49 | 2.05 % | $ 121 M | Nasdaq Global Select Market | ||
|
AxoGen
AXGN
|
$ 31.87 | 2.07 % | $ 1.47 B | Nasdaq Capital Market,SPB | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
Bio-Rad Laboratories
BIO
|
$ 275.33 | 2.19 % | $ 7.77 B | NYSE,SPB | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
Bruker Corporation
BRKR
|
$ 40.88 | 2.48 % | $ 6.09 K | Nasdaq Global Select Market,SPB | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
Boston Scientific Corporation
BSX
|
$ 75.65 | 2.97 % | $ 112 B | NYSE,SPB | ||
|
InMode Ltd.
INMD
|
$ 14.0 | 0.29 % | $ 905 M | Nasdaq Global Select Market,SPB | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
ClearPoint Neuro
CLPT
|
$ 14.09 | -7.06 % | $ 381 M | Nasdaq Capital Market | ||
|
CONMED Corporation
CNMD
|
$ 45.89 | -0.18 % | $ 1.42 B | NYSE,SPB | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
Cutera
CUTR
|
- | -10.19 % | $ 1.99 M | Nasdaq Global Select Market | ||
|
Nano-X Imaging Ltd.
NNOX
|
$ 2.48 | 1.02 % | $ 146 M | Nasdaq Global Select Market | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | ||
|
Electromed
ELMD
|
$ 24.18 | 1.09 % | $ 204 M | NYSE American | ||
|
Establishment Labs Holdings
ESTA
|
$ 77.41 | -1.12 % | $ 2.18 B | Nasdaq Capital Market | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
FONAR Corporation
FONR
|
$ 18.53 | -0.3 % | $ 121 M | Nasdaq Capital Market | ||
|
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | ||
|
Globus Medical
GMED
|
$ 96.27 | 0.06 % | $ 13 B | NYSE,SPB | ||
|
Tandem Diabetes Care
TNDM
|
$ 26.14 | 0.5 % | $ 1.78 B | Nasdaq Global Market,SPB | ||
|
Helius Medical Technologies
HSDT
|
$ 2.11 | -2.76 % | $ 1.28 M | Nasdaq Capital Market | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.73 | 2.57 % | $ 39.7 M | Nasdaq Capital Market | ||
|
Inogen
INGN
|
$ 6.4 | 6.53 % | $ 151 M | Nasdaq Global Select Market,SPB | ||
|
IRIDEX Corporation
IRIX
|
$ 1.47 | -2.0 % | $ 23.7 M | Nasdaq Global Select Market | ||
|
IRadimed Corporation
IRMD
|
$ 102.4 | 1.89 % | $ 1.3 B | Nasdaq Global Select Market |